WeedMD, a federally-licensed producer and distributor of medical and adult-use cannabis, has secured an amendment to its Health Canada licences allowing the Company to produce, package, sell and distribute all cannabis formats directly from its 610,000-square-foot flagship cultivation and processing site in Strathroy, Ontario.
The company’s hybrid-greenhouse in Strathroy is currently operating at full capacity under a 210,000 square foot canopy alongside additional drying and processing space. It’s 27-acre, low-cost, outdoor grow, now in its second year of operation, is located on site along with a 50,000 square foot stand-alone, licensed processing facility dedicated for outdoor cannabis processing.
As per the company’s press release, the outdoor harvest is expected to start in early October 2020 and will provide terpene-rich, high-cannabinoid input material for extraction and dried flower product formats such as pre-rolls and ready-to-roll.
WeedMD’s fully-licensed, extraction centre-of-excellence in Aylmer, ON produces the Company’s cannabis derivatives, and its fully-licensed Bowmanville, ON facility houses the Company’s medical fulfilment and distribution activities as well as its award-winning client services team.
“The ability to sell our growing portfolio of cannabis products to provincial distributors and the medical market from our Strathroy cultivation hub will accelerate our path to profitability as we continue to execute on our consolidation plans – achieving operational efficiencies with speedier product fulfilment,” remarked Angelo Tsebelis, CEO of WeedMD.
“Additionally, it provides us with the flexibility to further commercialize the ready-to-use space at our modern greenhouse in Strathroy for the production and shipment of high-margin new cannabis formats such as a variety of extracts, topicals and edibles. It also provides a runway for growth should we elect to scale-up or consider future expansion opportunities and partnerships.”